HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

2nd Edition of International Conference

and Expo on Clinical Microbiology

June 23-24, 2023 | Rome, Italy

ICCM 2023

AC Matin, Speaker at Clinical Microbiology Events
Keynote Presentation (In-Person)
AC Matin, Stanford University, United States

Bacteria like Escherichia coli cause disease but are also useful in resource regeneration. Its UPEC strain causes cystitis, which is treated by gentamicin. The protein Ys, encoded by the rpoS gene, controls E. coli resistance to antimicrobial agents. We discovered that rpoS delet [....] » Read More

Jawad Alzeer, Speaker at Clinical Microbiology Conferences
Keynote Presentation (Virtual)
Jawad Alzeer, University of Zurich, Switzerland

Homeostasis is the ability of the body to regulate and maintain its internal biological processes. Buffers, which consist of two interacting components, play a crucial role in maintaining homeostasis and overall health. In the body, these buffers can regulate various systems, suc [....] » Read More

Muhammad Morshed, Speaker at Clinical Microbiology Conferences
Keynote Presentation (Virtual)
Muhammad Morshed, University of British Columbia, Canada

Lyme Disease (LD) is a tick transmitted infection caused by Borrelia burgdorferi. This is one of the most common vector borne diseases in North America. Its prevalence is quite low in British Columbia (BC) compared to eastern North America. BC has a long history of studying and p [....] » Read More

Bohinc Klemen, Speaker at Clinical Microbiology Conferences
Oral Presentation (In-Person)
Bohinc Klemen, Faculty of Health Sciences, University of Ljubljana, Slovenia

The application of orthopedic implants in our body is associated with the possibility of infection. To have the infections under control interactions between microorganisms and implant surfaces needs to be understood. Therefore, in this presentation we consider the microbial adhe [....] » Read More

Tanyi Pride Bobga, Speaker at Clinical Microbiology Conferences
Oral Presentation (In-Person)
Tanyi Pride Bobga, University of Buea, Cameroon

Abstract: Diabetes remains a global public health concern in the world. Much is known about the burden of type 2 diabetes as opposed to type 1 diabetes mellitus (T1DM) hence underdiagnoses is evident. Diabetes type 1 is often associated with multiple symptoms and patients with t [....] » Read More

Geeta Chitre, Speaker at Clinical Microbiology Conferences
Oral Presentation (In-Person)
Geeta Chitre, Sadhu Vaswani Mission’s Medical Complex, India

The incidence of living donor kidney transplants is increasing globally due to advances in structural set ups, improved techniques in detections of tissue compatibilities, expertise in the procedures and availability of necessary resources. However, considering the immunosuppress [....] » Read More

Saiema Ahmedi, Speaker at Clinical Microbiology Events
Oral Presentation (In-Person)
Saiema Ahmedi, Senior Research Fellow, Department of Biosciences, Jamia Millia Islamia, New Delhi, India, India

Multidrug resistance and high toxicity towards conventional antifungal drugs is causing serious concern worldwide. Exploration of novel compounds with immense therapeutic potential is required. The present study evaluates the antifungal potential of limonene, a secondary metaboli [....] » Read More

Noha Tharwat Abou El Khier, Speaker at Medical Microbiology Conferences
Keynote Presentation (Virtual)
Noha Tharwat Abou El Khier, Mansoura University, Egypt

Multi drug resistance (MDR) is becoming a global problem for public health which threatens the lives of hospitalized individuals as well as increases health care costs and long-time treatment. MDR in Gram-negative bacteria, chiefly Enterobacteriaceae such as E. coli, has become o [....] » Read More

Abduh Murshed, Speaker at Clinical Microbiology Conferences
Oral Presentation (In-Person)
Abduh Murshed, Tongji University, China

Objective: Systemic Lupus Erythematosus is an autoimmune systemic connective tissue disease that affects many organs. The disease can be seen at any age period with more frequent females at different clinical stages. Many autoantibodies are shown in blood circulation in patients [....] » Read More

Brankica Filipic, Speaker at Applied Microbiology Conference
Oral Presentation (In-Person)
Brankica Filipic, University of Belgrade-Faculty of Pharmacy, Serbia

Since March 2020, when the WHO declared the COVID-19 pandemic, many patients infected with SARS-CoV-2 needed to be admitted to the Intensive care unit (ICU), and those with severe form of the disease had to be supported with mechanical ventilation. Although mechanical ventilation [....] » Read More

Lorena Abadia Patino, Speaker at Clinical Microbiology Conferences
Oral Presentation (Virtual)
Lorena Abadia Patino, IIBCAUDO, Venezuela

Atorvastatin is widely used in the adult population with dyslipidemia disorders. Recently, it was known that statins have antibacterial activity. For this reason, the effect of atorvastatin on the gut (gut microbiota habitat) was studied. An in vivo experimental study was carried [....] » Read More

Vijay Prabha, Speaker at Bacteriology Conferences
Oral Presentation (Virtual)
Vijay Prabha, Panjab University, India

Bacterial infections in the genital tract are one of the causes of female infertility worldwide with a prevalence rate of 30–40 %. Infertility in these cases is generally recognized as a consequence of inflammation. Bacteria may lead to inflammation due to the presence of L [....] » Read More

Jaime D Acosta Espana, Speaker at Clinical Microbiology Conferences
Oral Presentation (Virtual)
Jaime D Acosta Espana, Jena Microbioal Resource Collection, Germany

Mucormycosis is a fungal infection caused by members of the order Mucorales, the most prominent group among zygosporic fungi (formerly ascribed to Zygomycetes). A total of 26 mucoralean species can infect humans. Among these, the highest proportions of infections are caused by Rh [....] » Read More

Jazmin Cortez Gonzalez, Speaker at Clinical Microbiology Conferences
Oral Presentation (Virtual)
Jazmin Cortez Gonzalez, National Technological Institute of Mexico, Mexico

The design and control of biological reactors depends upon the correct calibration and selection of kinetic parameters from the exponential phase in the microbial growth. Nowadays, kinetic microbial parameters reported in the literature of biochemical engineering are obtained bas [....] » Read More

Avinash Singh, Speaker at Clinical Microbiology Conferences
Oral Presentation (Virtual)
Avinash Singh, Post doc Scientist at University of Minnesota, United States

Heterogeneous vancomycin intermediate Staphylococcus aureus (hVISA) strains are increasingly reported and their association with vancomycin treatment failure is a well-known problem worldwide. Methicillin resistant S. aureus (MRSA)(n=500) were screened for hVISA by four different [....] » Read More

Seyed adolmajid khosravani, Speaker at Clinical Microbiology Conferences
Poster Presentation (In-Person)
Seyed adolmajid khosravani, Yasuj University of Medical Sciences, Iran (Islamic Republic of)

Objective: Human gastrointestinal tract microbiota plays roles in metabolism and interaction with the host cells through several mechanisms such as outer membrane vesicle (OMVs). This study aims to address the effects of Bacteroides thetaiotaomicron (B. thetaiotaomicron) OMV [....] » Read More

Adriano Alberti, Speaker at Clinical Conferences
Poster Presentation (In-Person)
Adriano Alberti, Universidade do Sul de Santa Catarina, Brazil

At the end of 2019, a new disease with pandemic potential appeared in China. It was a novel coronavirus called coronavirus disease 2019 (COVID-19). Later, in the first quarter of 2020, the World Health Organization declared the outbreak of this disease a pandemic. Brazil is one o [....] » Read More

Jiewen Guan, Speaker at Medical Microbiology Conferences
Poster Presentation (Virtual)
Jiewen Guan, Canadian Food Inspection Agency, Canada

Ingestion of antibiotic-resistant (AR) bacteria may lead to transmission of AR genes in the gut microbiota and cause AR bacterial infection, a significant public health concern. However, it is not clear if and how microbes from the food matrix (food microbes) may influence resist [....] » Read More

Guillermo Bracamonte, Speaker at Clinical Microbiology Conferences
Poster Presentation (Virtual)
Guillermo Bracamonte, National University of Cordoba (UNC), Argentina

In this presentation is presented advances in Nanotechnology based on metallic and semiconductors Nanoparticles by the design of varied Nanoarchitectures as functional Nanoplatforms. By this manner, varied sizes and chemical surfaces could be obtained. And in these perspectives t [....] » Read More

Rafik Aniba, Speaker at Medical Microbiology Conferences
Poster Presentation (Virtual)
Rafik Aniba, Casablanca, Morocco

Pathogenic bacteria are characterized by their ability to adhere to a surface and form a protective biofilm, highly tolerant to antimicrobial agents. In routine medical microbiology, the classical techniques of antibiogram: agar diffusion method or liquid microdilution method are [....] » Read More

Amel Halimi, Speaker at Clinical Microbiology Conferences
Poster Presentation (Virtual)
Amel Halimi, University of Tlemcen, Algeria

Objective: Infections caused by Proteus mirabilis are difficult to treat due to the acquisition of various antibiotic resistance mechanisms. The present work aims to examine the correlation between biofilm formation and antibiotic resistance in clinical isolates of Proteus mirabi [....] » Read More